Community Protocol
Pinealon
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Educational and calculation-reference material only. Community reports are uncontrolled anecdotes and do not replace professional medical guidance, product labeling, or individualized clinical monitoring.
Scope
Preparation examples, syringe conversion, community-reported patterns and important limitations.
Available strengths: 20 MG
Preparation Examples
These are calculation examples only. The concentration assumptions below are explicit so syringe units are never separated from vial strength and diluent volume.
| Setup | Diluent | Concentration | Unit conversion |
|---|---|---|---|
| 20 MG vial – 2 mL example | Add 2 mL bacteriostatic water | 10 mg/mL | Each U-100 unit = 100 mcg |
| 20 MG vial – 1 mL example | Add 1 mL bacteriostatic water | 20 mg/mL | Each U-100 unit = 200 mcg |
Syringe Conversion
| Reported amount | 20 MG setup | 20 MG setup |
|---|---|---|
| 1 mg | 10 units | 5 units |
| 2.5 mg | 25 units | 12.5 units |
| 5 mg | 50 units | 25 units |
| 10 mg | 100 units | 50 units |
Always recalculate from the actual vial strength and diluent volume. A U-100 unit is 0.01 mL; it is not a dose by itself.
Community-Reported Patterns
| Recurring report | Frequency seen | Context in reports |
|---|---|---|
| 2.5-5 mg | Once daily | Lower-start reports |
| 5-10 mg | Daily for 10-20 days | Most recurring cycle |
| 10 mg | Once daily | Higher experimental use |
Observations
- Community discussions most often centered on memory, focus, sleep and healthy-aging goals.
- The amount, frequency, route and cycle length varied substantially between reports.
- Reported outcomes were commonly confounded by diet, training, other products or existing treatment.
Caveats
- Human evidence and long-term safety are limited; community cycle patterns are not validated treatment protocols.
- Community reports are uncontrolled anecdotes and do not establish an appropriate dose, safety, product identity, purity or efficacy.